Healthcare - Biotechnology - NASDAQ - CH
$ 47.25
0.854 %
$ 4.03 B
Market Cap
-18.03
P/E
Price Target
Average
56.31%
Revenue Forecast
Estimate
46.42%
EBIT
Estimate
--32.81%
Net Income
Estimate
30.64%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
CRISPR Therapeutics AG
Wall Street analysts predict an average 1-year price target for CRSP of $73.9 , with forecasts ranging from a low of $52 to a high of $100 .
CRSP Lowest Price Target
Wall Street Target
52 USD
10.05%
CRSP Average Price Target
Wall Street Target
73.9 USD
56.31%
CRSP Highest Price Target
Wall Street Target
100 USD
111.64%
REVENUE FORECAST
Revenue Forecast Chart CRSP
EBIT FORECAST
EBIT Forecast Chart CRSP
NET INCOME FORECAST
Net Income Chart CRSP